In this article, the author discusses the need to build an economic value strategy that addresses the sometimes disparate perspectives of key stakeholders. To read the article, click the link below.
Rare disease PMA trends in France: Price achieved vs. disease prevalence
In this installment, we examine the relationship between launch prices in France and disease prevalence as reported in the Haute Autorité de Santé assessments.